BWAY BrainsWay Ltd.

11.62USD-2.27%Mkt Cap: 467.74M $P/E: 52.82

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the…

Key Statistics

Company
Market Cap467.74M USD
Enterprise Value422.16M USD
Revenue (TTM)60.70M USD
Gross Profit39.39M USD
Net Income (TTM)7.63M USD
Revenue/Share1.56 USD
Last Price11.62 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees129
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)52.82
P/E (Forward)23.47
PEG—
EV/EBITDA49.77
EV/Revenue6.96
P/S7.89
P/B6.03
EPS (TTM)0.22
EPS (Forward)0.51
52W Range
7.13544% of range17.40
52W High17.40 USD
52W Low7.135 USD
Profitability
Gross Margin75.42%
Oper. Margin13.98%
EBITDA Margin13.98%
Profit Margin14.62%
ROE10.42%
ROA6.76%
Growth
Revenue Growth35.40%
Earnings Growth59.80%
Cash Flow & Leverage
Operating CF18.02M USD
CapEx (TTM)1.75M USD
FCF Margin-10.14%
FCF Yield-1.32%
Net Debt-54.98M USD
Net Debt/EBITDA-6.48
Balance Sheet
Debt/Equity0.09
Current Ratio3.59
Quick Ratio3.05
Book Value/Sh1.97 USD
Cash/Share1.55 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateMar 4, 2026
Analyst Consensus
Rating—
Target (Mean)19.27 USD
Upside (mean)+65.8%
Target Range18.80 USD – 20.00 USD
18.80+65.8% to mean20.00
# Analysts3
Ownership
Shares Out.40.25M
Float24.10M
Insiders2.59%
Institutions29.01%
Short Interest
Short Ratio2.3d
Short % Float0.65%
Short % Out.0.50%
Shares Short199.57K
Short (prev mo.)156.37K
Technical
SMA 5014.41 (-19.3%)
SMA 20013.78 (-15.7%)
Beta0.10
S&P 52W Chg16.45%
Avg Vol (30d)94.67K
Avg Vol (10d)118.47K
Technical Indicators
RSI (14)23.0
MACD-0.6675
MACD Signal-0.5331
MACD Hist.-0.1344
BB Upper14.72 USD
BB Middle13.25 USD
BB Lower11.78 USD
BB Width22.19%
ATR (14)0.6076 USD
Vol Ratio (20d)1.26x